Caricamento...
EXTH-14. REPURPOSING OF APPROVED DRUGS FOR THE TREATMENT OF GLIOMA STEM CELLS
Glioblastoma (GBM) is the most common and malignant primary brain tumor. Glioma stem cells (GSCs), a subpopulation of GBM cells with stem cell properties, are responsible for the tumor initiation and recurrence, and therapeutic resistance. To develop novel therapeutic agents for sphere-forming patie...
Salvato in:
| Pubblicato in: | Neuro Oncol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217099/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.363 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|